Game Creek Capital, LP Pfizer Inc Transaction History

Game Creek Capital, LP

$249 Million
Q4 2024

A detailed history of Game Creek Capital, LP transactions in Pfizer Inc stock. As of the latest transaction made, Game Creek Capital, LP holds 233,375 shares of PFE stock, worth $6.24 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares

233,375

Previous 269,000 13.24%

Holding current value

$6.24 Million

Previous $7.78 Million 20.47%

% of portfolio

2.48%

Previous 3.63%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.8 - $30.19 $883,500 - $1.08 Million	-35,625 Reduced 13.24%	233,375 $6.19 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $1.15 Million - $1.31 Million	-41,625 Reduced 13.4%	269,000 $7.78 Million
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $85,252 - $99,900	3,375 Added 1.1%	310,625 $8.69 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $3.72 Million - $4.27 Million	143,750 Added 87.92%	307,250 $8.53 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $1.12 Million - $1.45 Million	42,750 Added 35.4%	163,500 $4.71 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.05 Million - $1.23 Million	-32,750 Reduced 21.34%	120,750 $4.01 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $451,499 - $522,375	12,500 Added 8.87%	153,500 $5.63 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $1.12 Million - $1.46 Million	-28,450 Reduced 16.79%	141,000 $5.75 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $764,025 - $997,350	-18,300 Reduced 9.75%	169,450 $8.69 Million
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $684,844 - $836,023	15,650 Added 9.09%	187,750 $8.22 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $307,098 - $364,122	-6,600 Reduced 3.69%	172,100 $9.02 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $4.28 Million - $5.3 Million	-93,550 Reduced 34.36%	178,700 $9.25 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $1.09 Million - $1.62 Million	-26,500 Reduced 8.87%	272,250 $16.1 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $686,875 - $882,350	17,500 Added 6.22%	298,750 $12.8 Million
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $781,042 - $884,790	21,750 Added 8.38%	281,250 $11 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $1.12 Million - $1.27 Million	33,500 Added 14.82%	259,500 $9.4 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $845,117 - $1.07 Million	-25,250 Reduced 10.05%	226,000 $8.32 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $142,875 - $167,625	4,500 Added 1.82%	251,250 $9.22 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $5.35 Million - $6.49 Million	177,750 Added 257.61%	246,750 $8.07 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $628,447 - $897,914	23,250 Added 50.82%	69,000 $2.25 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $304,510 - $345,580	-9,250 Reduced 16.82%	45,750 $1.79 Million
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $56,857 - $73,727	1,750 Added 3.29%	55,000 $1.98 Million
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $822,804 - $923,820	-22,250 Reduced 29.47%	53,250 $2.31 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $394,317 - $449,565	-10,250 Reduced 11.95%	75,500 $3.3 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.01 Million - $1.22 Million	-29,250 Reduced 25.43%	85,750 $3.78 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1.15 Million - $1.23 Million	-35,000 Reduced 23.33%	115,000 $4.17 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $4.46 Million - $5.18 Million	139,800 Added 1370.59%	150,000 $5.32 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $339,252 - $359,958	10,200	10,200 $0

Others Institutions Holding PFE

# of Institutions

3,357

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Game Creek Capital, LP with notifications on news.

Account

Game Creek Capital, LP Pfizer Inc Transaction History